Kristoffer Rohrberg

Ass. Professor

Faculty of Health and Medical Sciences, University of Copenhagen

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Ignacio Melero

SPAIN

View details

Neil H. Segal

Weill Cornell Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kristoffer Rohrberg

Research Interests

Explore related searches

Contact this professor

Articles (10)

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors

CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors

Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors The JAVELIN PARP Medley Nonrandomized Controlled Trial

Clinical implication of genetic intratumor heterogeneity for targeted therapy in head and neck cancer

Comprehensive analysis of causes for unsuccessful genomic profiling in a Phase 1 setting

Copenhagen Prospective Personalized Oncology (CoPPO) The utility of using genomic profiling for tailored therapy in a Phase 1 setting

DNA methylation markers for sensitive detection of circulating tumor DNA in plasma from patients with gastroesophageal adenocarcinomas

Collaborators (2)

Ignacio Melero

Neil H. Segal

Make your next move.